4//SEC Filing
Mazabraud Yann 4
Accession 0001104659-24-047957
CIK 0001649904other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 8:11 PM ET
Size
17.5 KB
Accession
0001104659-24-047957
Insider Transaction Report
Form 4
Mazabraud Yann
EVP, Head of International
Transactions
- Disposition to Issuer
Restricted Stock Units
2024-04-15−6,874→ 0 total→ Common Stock (6,874 underlying) - Award
Restricted Stock Units
2024-04-15+8,905→ 8,905 total→ Common Stock (8,905 underlying) - Award
Restricted Stock Units
2024-04-15+10,000→ 10,000 total→ Common Stock (10,000 underlying) - Disposition to Issuer
Restricted Stock Units
2024-04-15−2,031→ 0 total→ Common Stock (2,031 underlying) - Exercise/Conversion
Common Stock
2024-04-14−10,375→ 34,870 total - Exercise/Conversion
Restricted Stock Units
2024-04-14−10,375→ 31,125 total→ Common Stock (10,375 underlying)
Footnotes (8)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date.
- [F3]The restricted stock units were rescinded and cancelled by mutual agreement of the reporting person and Issuer. The reporting person received French-qualified restricted stock units on April 15, 2024 as consideration for the recission and cancellation of the unvested portion of the restricted stock previously received on February 11, 2021.
- [F4]The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.
- [F5]The restricted stock units were rescinded and cancelled by mutual agreement of the reporting person and Issuer. The reporting person received French-qualified restricted stock units on April 15, 2024 as consideration for the recission and cancellation of the unvested portion of the restricted stock previously received on February 9, 2022.
- [F6]The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.
- [F7]The restricted stock units vest in full on April 15, 2025. The restricted stock units have no expiration date.
- [F8]The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001774702
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 8:11 PM ET
- Size
- 17.5 KB